Thematic Series: Call for Papers

With a special grant from the University of Macau, the manuscripts to be published in the following thematic series will receive full sponsorship of article processing charges (APC) and expedited copyediting. These manuscripts would significantly enhance the journal’s quality and reputation. Hence, manuscripts on your leading research in Chinese medicine are most welcome.

Abstract Submission

If you are interested in contributing a manuscript, please send an abstract to: cmjournal@gmail.com. Preferred types of manuscripts include systematic literature reviews, new research methods, scientific research articles and evidence-led commentary articles. If you have any question, please contact us before submission of full manuscripts.

Deadline for abstract and manuscript submission: 31 December 2016

Thematic series 1: Advances in Chinese medicines research through cutting-edge technologies

Much of recent Chinese medicine research has been advanced through cutting-edge technologies. In order to promote and facilitate scientists to conduct advanced research into Chinese medicine and boost confidence of practitioners and consumers in Chinese medicine products, we would need to explain, using the best sciences and good practices being introduced into the state-of-the-art Chinese medicine, to develop a more lucid and in-depth understanding. This thematic series publishes the recent advances in Chinese medicine research and the cutting-edge technologies that enabled the advances.

Examples of topics

Chinese medicinal research on treatments of major diseases

  • Neurodegenerative diseases
  • Cardiovascular diseases
  • Cancer
  • Diabetes
  • Infectious diseases
  • Liver diseases
  • Skin diseases

Technological research on Chinese medicine practices

  • Molecular authentication of medicinal materials
  • Functional MRI and acupuncture
  • Biophotonic devices
  • Biochips
  • Personal genomics
  • Translational medicine that involves Chinese medicine


Thematic series 2: Evidence-based medicine

Complementary medicine and Chinese medicine are indispensable parts of healthcare in modern society. Studies on their effective uses are increasing in number and quality. This is mainly attributed to the availability of methods and guidelines developed in evidence-based medicine. In order to show the evidence from scientific research and give the confidence to the practitioners and consumers, researchers are striving to conduct evidence-based studies including rigorous statistical analysis, randomized clinical trials, systematic reviews and meta-analysis. This thematic series publishes the methods and applications of evidence-based Chinese medicine.

Examples of topics

  • Critical appraisal of research findings
  • Statistical reporting of scientific research
  • Reporting guidelines
  • Design and analysis of randomized controlled trials
  • Systematic literature (qualitative) reviews
  • Systematic reviews of clinical trials
  • Meta-analysis and network meta-analysis
  • Open systematic reviewing (e.g. for living systematic reviews)

Thematic series 3: Efficacy of active compounds identified from Chinese medicine prescriptions

Chemical compounds in Chinese medicine prescriptions synergistically function in a many-to-many relationship involving multi-components and multi-targets. Moreover, the novel technologies for developing new drugs from Chinese medicine prescriptions should be evaluated. This thematic series publishes the recent chemical and pharmacological advances in developing new drugs from Chinese medicine prescriptions.

Examples of topics

  • Novel technologies for identifying active compounds from Chinese medicine prescriptions
  • Leading technologies for investigation of therapeutic targets
  • Advanced technologies for quality control of Chinese medicine prescriptions
  • The properties of recently identified active compounds and their derivatives
  • The potentials of the identified active compounds for drug development

Thematic series 4: Active compounds of Chinese medicines for cancer therapy

Chinese medicines are rich with active compounds that are druggable for cancer therapy. Some active compounds from Chinese medicines are identified as promising anti-cancer compounds, such as tanshinone IIA from Salvia miltiorrhiza. Pharmaceutical research improved the bioavailability of these active compounds for clinical application. This thematic series will select and publish key papers in this field.

Examples of topics

  • The pharmacological properties of chemical compounds identified from Chinese medicines for cancer therapy
  • Drug delivery system development for cancer therapy

Thematic series 5: Natural products from Chinese medicines against complex diseases

Complex diseases lack definitively efficacious therapeutics in Western medicine. Natural products have been useful for developing more effective therapeutics in treating complex diseases. This thematic series publishes the recent advances in research on natural products from Chinese medicines for treating complex diseases.

Examples of topics

Natural products from Chinese medicines that are effective in treating:

  • Alzheimer's disease
  • Asthma
  • Atherosclerosis
  • Autoimmune diseases
  • Cancer
  • Diabetes
  • Multiple sclerosis
  • Obesity
  • Osteoporosis
  • Parkinson's disease

Thematic series 6: Intellectual properties of Chinese medicine

Chinese medicine should meet the challenges in protecting its intellectual properties under the current legal systems. Intellectual property protection is crucial to preserving the integrity of Chinese medicine knowledge and fostering innovation by prohibiting pirates. This thematic series will publish key papers on the latest research into intellectual properties in relation to Chinese medicine.

Examples of topics

  • New patenting strategies for Chinese medicine
  • Survey on the trademarks of herbal products under threats
  • Feasible trade secret strategies for herbal products
  • Unresolved copyright protection issues of Chinese medicine
  • Scientometric monitoring of herbal intellectual properties
  • Validation of intellectual property valuation in Chinese medicine
  • Case studies on commercialization of Chinese herbal intellectual capital
  • Models for optimization and management of Chinese medicine intellectual properties

Thematic series 7: Good Practices (GxP) for Chinese medicine through emerging technologies and management

Modern development of Chinese medicine demands the Good Practices (GxP), such as GAP, GMP, GCP, GLP and GSP, developed for Chinese medicine to innovate its technologies and management. We would need to standardize the GxP through emerging technologies and disseminate them to upgrade the Chinese medicine research and development. This thematic series will publish the recent advances in developing GxP for Chinese medicine. This thematic series aims to provide understanding of the recent progress in GxP for Chinese medicine, from both management and technological perspectives.

Examples of topics

Emerging technologies in GxP for Chinese medicine

  • Chinese herbal sources
  • Clinical trials of Chinese medicine
  • Chinese medicine products
  • Quality traceability technologies

Management efforts of GxP for Chinese medicine

  • Standardization, dissemination and evaluation

Advertisement